Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 987 | 1127 | 1148 | 1304 | 1319 | 1485 |
Fund Return | -1.28% | 12.66% | 14.82% | 9.25% | 5.69% | 4.04% |
Place in category | 215 | 133 | 6 | 33 | 161 | 72 |
% in Category | 57 | 38 | 2 | 10 | 51 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brandes International Equity I | 819.35M | 14.66 | 10.11 | 5.73 | ||
Brandes International Small Cap EqI | 569.38M | 24.15 | 13.80 | 6.95 | ||
Brandes Emerging Markets Value I | 511.02M | 4.75 | 1.60 | 0.31 | ||
Brandes Emerging Markets Value A | 179.96M | -5.07 | 0.44 | 1.13 | ||
Brandes International Small Cap Equ | 76.47M | -1.68 | 13.65 | 5.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 41.1B | 9.56 | 5.86 | 4.02 | ||
Fidelity Series International VVV | 15.93B | 15.34 | 9.75 | 5.72 | ||
Vanguard International Value Inv | 13.97B | 7.98 | 3.06 | 4.30 | ||
Causeway International Value Instl | 11.04B | 11.15 | 9.40 | 5.50 | ||
DFA International Value I | 9.48B | 12.66 | 9.29 | 5.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Takeda Pharmaceutical | JP3463000004 | 3.31 | 4,240.0 | +0.95% | |
Rolls-Royce Holdings | GB00B63H8491 | 3.00 | 530.20 | -0.60% | |
Heineken | NL0000008977 | 2.57 | 66.95 | -0.15% | |
Alibaba | KYG017191142 | 2.53 | 113.90 | +3.55% | |
Sanofi | FR0000120578 | 2.53 | 101.72 | +1.50% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review